FATE
Price
$1.53
Change
-$0.00 (-0.00%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
177.61M
13 days until earnings call
Intraday Buy/Sell Signals
RPTX
Price
$1.86
Change
-$0.04 (-2.11%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
79.9M
20 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

FATE vs RPTX

Header iconFATE vs RPTX Comparison
Open Charts FATE vs RPTXBanner chart's image
Fate Therapeutics
Price$1.53
Change-$0.00 (-0.00%)
Volume$21.36K
Capitalization177.61M
Repare Therapeutics
Price$1.86
Change-$0.04 (-2.11%)
Volume$600
Capitalization79.9M
FATE vs RPTX Comparison Chart in %
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. RPTX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and RPTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (FATE: $1.54 vs. RPTX: $1.86)
Brand notoriety: FATE and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 86% vs. RPTX: 209%
Market capitalization -- FATE: $177.61M vs. RPTX: $79.9M
FATE [@Biotechnology] is valued at $177.61M. RPTX’s [@Biotechnology] market capitalization is $79.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than FATE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 6 TA indicator(s) are bullish while RPTX’s TA Score has 4 bullish TA indicator(s).

  • FATE’s TA Score: 6 bullish, 4 bearish.
  • RPTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, FATE is a better buy in the short-term than RPTX.

Price Growth

FATE (@Biotechnology) experienced а -4.35% price change this week, while RPTX (@Biotechnology) price change was +1.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.20%. For the same industry, the average monthly price growth was +16.20%, and the average quarterly price growth was +80.31%.

Reported Earning Dates

FATE is expected to report earnings on Oct 30, 2025.

RPTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-1.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($178M) has a higher market cap than RPTX($79.9M). RPTX YTD gains are higher at: 41.985 vs. FATE (-6.667). RPTX has higher annual earnings (EBITDA): -110.47M vs. FATE (-161.6M). FATE has more cash in the bank: 223M vs. RPTX (109M). RPTX has less debt than FATE: RPTX (649K) vs FATE (81.3M). FATE has higher revenues than RPTX: FATE (8.47M) vs RPTX (250K).
FATERPTXFATE / RPTX
Capitalization178M79.9M223%
EBITDA-161.6M-110.47M146%
Gain YTD-6.66741.985-16%
P/E RatioN/AN/A-
Revenue8.47M250K3,388%
Total Cash223M109M205%
Total Debt81.3M649K12,527%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATERPTX
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUMXF2.610.04
+1.56%
Supremex Inc.
KRNGF1.11N/A
N/A
KAROON ENERGY LTD.
NWSZF0.83N/A
N/A
CTF Services Limited
TDSGF0.04N/A
N/A
Telo Genomics Corp.
CMAKY5.35-0.16
-2.90%
China Minsheng Banking Corp., Ltd.

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with BCYC. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-2.11%
BCYC - RPTX
54%
Loosely correlated
+3.10%
INO - RPTX
51%
Loosely correlated
-3.15%
CADL - RPTX
43%
Loosely correlated
-9.29%
ALNY - RPTX
38%
Loosely correlated
+2.30%
AXON - RPTX
37%
Loosely correlated
+1.11%
More